N/A N=100 Technique for Successful Ultrasound-guided Peripheral Vascular Access
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=44 Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease
Kidney Diseases
Primary: Feasibility- Eligibility for Randomization — 54 Participants
N/A N=35 Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics
Vascular Access Device Complications
Primary: Percent Eligible Patients That Agreed to Participate — 80 percentage of eligible patients agreed t
Phase 2 N=67 Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Endothelial Dysfunction
Primary: Absolute Change in Brachial Artery Flow-mediated Dilation at Day 7 From Day 0 — 4.08; 2.77; 2.97; 2.66 % of preocclusion diameter
N/A N=22 Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction
Difficult Peripheral IV Access
Primary: Time to Successful Placement of a Functioning USGIV/IO — 163.7; 67.3 seconds
N/A N=182 Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest
Cardiac Arrest
Primary: First Attempt Success Rate Between the Tibial IO, Humeral IO, and Peripheral IV. — 26; 17; 58 Participants
N/A N=14 Vascular Dysfunction During Physical Inactivity
Aging · Vascular Endothelium · Skeletal Muscle
Primary: Brachial Artery Vascular Function — 5.1; 3.1; 4.4 percent vasodilation
N/A N=301 Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults
Asthma · Communication
Primary: Score of Asthma Control Questionnaire — -0.48; -0.27 score on a scale
N/A N=30 Tele-Health Electronic Monitoring to Reduce Post Discharge Complications and Surgical Site Infections
Peripheral Vascular Disease
Primary: 30-Day Readmission (Any) — 4; 2 Participants
N/A N=1,552 Study Of Telemedicine Consultation at Home For Older Adults
Physical Disorders · Telemedicine
Primary: Emergency Department Use — 0.1050; 0.0885 Emergency dept use rate per person-month — p=0.017
N/A N=263 MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study
Femoral Arteriotomy Closure
Primary: Time to Hemostasis — 65.4 seconds
N/A N=270 Comparison of Different Techniques on First Attempt Success in Difficult Vascular Access Patients
Vascular Access
Primary: Number of Participants With Success in the First Attempt — 56; 71; 53 Participants
N/A N=46 Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation
Chronic Kidney Disease · Chronic Kidney Disease Requiring Chronic Dialysis
Primary: Mean Scores of a Questionnaire Evaluating Patient Confidence in Navigating Vascular Access Care Pre- to Post-program Implementation — 8.0; 8.7 score on a scale — p=0.20
N/A N=50 Ultrasound-Guided Peripheral Venous Access Using AccuCath
Intravenous Access
Primary: First Attempt Success Rate — 17; 11 Participants
Phase 3 N=106 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Multiple Sclerosis
Primary: The Number of Subjects Rating the Suitability of RebiSmart at the End of 12-week Treatment Period for Self-injecting Rebif® New Formulation (RNF). — 73; 21; 8 participants